On Air Now

Listen

Listen Live Now » 101.1 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
38° Feels Like: 27°
Wind: SE 23 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Rain/Snow Showers/Wind 40°

Tonight

Rain 36°

Tomorrow

AM Rain/Snow Showers 46°

Alerts

Roche says Japan approves new formulation of arthritis drug

ZURICH (Reuters) - Roche Holding AG's Japanese subsidiary Chugai said on Monday that Japanese health regulators have approved a new formulation of its rheumatoid arthritis drug Actemra.

Japanese regulators have approved a subcutaneous formulation of Actemra which shortens the delivery time of the drug compared to an intravenous formulation and can be administered at home.

Actemra was first launched with intravenous formulation in Japan for Castleman's disease and was later approved for rheumatoid arthritis.

Roche has also submitted the subcutaneous formulation for approval in the United States and Europe, where Actemra is approved for use in rheumatoid arthritis patients who are either intolerant to or have failed to respond to other medicines to treat inflammation.

(Reporting by Caroline Copley)

Comments